# China NMPA Drug Inspection - Shizhentang Badong Pharmaceutical Co., Ltd. - Mulberry

Source: https://www.keypedia.com/records/china_drug_inspection/shizhentang-badong-pharmaceutical-co-ltd/0694a7a3-7846-48ed-b74b-38784bc7cd8f
Source feed: China

> China NMPA drug inspection for Shizhentang Badong Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Mulberry. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Shizhentang Badong Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Mulberry
- Inspection Finding: [Characteristics]
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.keypedia.com/companies/shizhentang-badong-pharmaceutical-co-ltd/a577feda-1f78-46b9-9f0c-b7c93f055fd4